Jockey Club’s 2017 Round Table Meeting in the Books
Edited Press Release
August 14, 2017
Topics covered included the Horseracing Integrity Act of 2017, Thoroughbred Safety Committee recommendations, and more.
Topics covered included the Horseracing Integrity Act of 2017, Thoroughbred Safety Committee recommendations, and more.
The FEI also announced that a Belgian show jumping horse has tested positive for a metabolite of the analgesic tramadol.
Labs in Australia, France, Great Britain, Hong Kong, and the United States earned reference laboratory accreditation.
The automatic test’s short run time enables a high throughput with minimal labor requirements, researchers say.
The board also approved a ban on injectable magnesium sulfate and will assess pergolide use for PPID horses.
The cases involve a Belgian endurance horse, a South African jumper, and a Mexican jumper.
Shiners Chic, ridden by Jessica Sternberg tested positive for the anabolic steroid at a CRI3* in Texas, in April.
All post-race drug testing at the upcoming Royal Ascot meet will be recorded using a smartphone app.
The standards were reviewed and modified at the ARCI’s equine welfare and racing integrity conference in April.
Policies include publishing daily vet records of all medications and treatments given to horses leading up to the race.
Mitragynine, known as Kratom, has performance-enhancing and analgesic effects similar to cocaine and morphine.
Among other points, the new bill would prohibit the use of any substance within 24 hours of a race.
The conference concluded with presentations by individuals from inside and outside the Thoroughbred industry.
Recommendations include adding to the forbidden drugs or substances list, creating educational efforts, and more.
Provisional suspensions were also lifted from three trainers and two horses.
A Cargill product, Progressive Nutrition Soothing Pink, was found to contain the banned substance ractopamine.
Stay on top of the most recent Horse Health news with
